These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31366502)

  • 1. Electron Microscopic Analysis of Stem Cells in Human Prostate Cancer, Including Inverted Capsule Embedding Methods for Archival Sections and Falcon Films for Prostate Cancer Cell Lines.
    Sinha AA
    Anticancer Res; 2019 Aug; 39(8):4171-4177. PubMed ID: 31366502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133.
    Sinha AA; Wilson MJ
    Anticancer Res; 2018 Oct; 38(10):5725-5732. PubMed ID: 30275193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
    Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
    Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
    Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
    Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
    Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
    Shepherd CJ; Rizzo S; Ledaki I; Davies M; Brewer D; Attard G; de Bono J; Hudson DL
    Prostate; 2008 Jun; 68(9):1007-24. PubMed ID: 18398820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
    Coogan CL; Bostwick DG; Bloom KJ; Gould VE
    Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the Expression of Biomarkers in Prostate Cancer Cell Lines.
    Su CY; Huang GC; Chang YC; Chen YJ; Fang HW
    In Vivo; 2021; 35(3):1545-1548. PubMed ID: 33910833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification of a novel antibody for CD133 using human antibody phage display.
    Glumac PM; Forster CL; Zhou H; Murugan P; Gupta S; LeBeau AM
    Prostate; 2018 Sep; 78(13):981-991. PubMed ID: 29790189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on carcinogenesis of human prostate. III. Long-term explant culture of normal prostate and benign prostatic hyperplasia: transmission and scanning electron microscopy.
    Heatfield BM; Sanefuji H; Trump BF
    J Natl Cancer Inst; 1982 Oct; 69(4):757-66. PubMed ID: 6181280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.
    Petkova N; Hennenlotter J; Sobiesiak M; Todenhöfer T; Scharpf M; Stenzl A; Bühring HJ; Schwentner C
    Prostate; 2013 Oct; 73(14):1576-90. PubMed ID: 23836489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scanning and transmission electron microscopy of human prostatic acinar cells.
    Stone MP; Stone KR; Ingram P; Mickey DD; Paulson DF
    Urol Res; 1977; 5(4):185-200. PubMed ID: 74116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
    Brown MD; Gilmore PE; Hart CA; Samuel JD; Ramani VA; George NJ; Clarke NW
    Prostate; 2007 Sep; 67(13):1384-96. PubMed ID: 17639507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    Rentala S; Mangamoori LN
    J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
    Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
    Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
    Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
    Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.